Edition:
United States

Medinet Co Ltd (2370.T)

2370.T on Tokyo Stock Exchange

127JPY
22 Sep 2017
Change (% chg)

¥0 (+0.00%)
Prev Close
¥127
Open
¥127
Day's High
¥127
Day's Low
¥125
Volume
710,000
Avg. Vol
2,099,881
52-wk High
¥205
52-wk Low
¥121

Chart for

About

MEDINET Co., Ltd. is a Japan-based medical support service provider. The Company's main business is divided into three divisions. The immune-cell therapy integrated support service division includes the planning, design, installation, operation, maintenance and management of cell processing centers (CPCs), the licensing of CPCs,... (more)
No analyst recommendations are available for .

Overall

Beta: 2.08
Market Cap(Mil.): ¥13,480.20
Shares Outstanding(Mil.): 106.14
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 81.40 16.08
EPS (TTM): -- -- --
ROI: -- 3.18 14.60
ROE: -- 4.93 14.03

BRIEF-Medinet says exercise of options

* Says 13,500 units of its 12th series options were exercised to 1.4 million shares of its common stock from Aug. 1 to Aug. 14

Aug 15 2017

BRIEF-Medinet says exercise of options

* Says 14,250 units of its 12th series options were exercised to 1.4 million shares of its common stock from July 20 to July 26

Jul 27 2017

BRIEF-Medinet says exercise of options

* Says 20,000 units of its 12th series options were exercised to 2 million shares of its common stock from July 12 to July 19

Jul 20 2017

BRIEF-Medinet announces exercise of warrants and options

* Says warrants issued with co's third series unsecured convertible bonds were exercised into 1.5 million shares, from July 1 to July 11

Jul 12 2017

BRIEF-Medinet receives patent in Japan

* Says it and Okayama University received a patent (No. 2013-531595) for manufacture method of antibody detection drug in Japan

Jul 10 2017

BRIEF-Medinet to issue new shares and unsecured convertible bonds

* Says it will issue 1.4 million new shares, at the price of 118 yen and raise 161.9 million yen

Jun 01 2017

BRIEF- Medinet signs agreement with KENKOIGAKU ASSOCIATON

* Says it signed an agreement with KENKOIGAKU ASSOCIATON, regarding contract manufacturing of specific cell processing

May 21 2017

Earnings vs. Estimates